Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6CM1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,563
Award facts
- Contract value 100% obligated
- $14,563.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on December 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. The order, valued at $14,563.37 with a firm fixed price structure, is scheduled for completion by December 19, 2025, and will be fulfilled from the company's Conshohocken, Pennsylvania facility. This delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's ability to deliver specialty medications such as Zepbound—a GLP-1 receptor agonist indicated for weight management—demonstrates its role in supporting the medical supply needs of the Department of Defense across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F6CM1?
SPE2DR26F6CM1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F6CM1 worth?
The government has obligated $14,563 on SPE2DR26F6CM1.
Is contract SPE2DR26F6CM1 an order under another contract?
Yes. SPE2DR26F6CM1 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6CM1 competed?
The extent of competition for SPE2DR26F6CM1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award